MUCOSAL MELANOMA
Clinical trials for MUCOSAL MELANOMA explained in plain language.
Never miss a new study
Get alerted when new MUCOSAL MELANOMA trials appear
Sign up with your email to follow new studies for MUCOSAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New triple therapy aims to halt rare, aggressive melanoma
Disease control Not yet recruitingThis study tests a combination of two drugs (carilizumab and apatinib mesylate) plus radiation therapy as a first treatment for advanced mucosal melanoma, a rare and aggressive skin cancer. About 30 adults who have not had prior systemic treatment will receive this triple therapy…
Matched conditions: MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated May 17, 2026 03:10 UTC
-
New cocktail of drugs targets tough melanomas in early trial
Disease control Not yet recruitingThis study tests a combination of two experimental drugs (iparomlimab and tuvoraleimab) plus standard chemotherapy and a blood-vessel blocker in people with advanced acral or mucosal melanoma. About 48 adults who have had little or no prior treatment will take part. The goal is t…
Matched conditions: MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 14, 2026 12:04 UTC